4

FORM 4 SUBMISSION

Company: Mirum Pharmaceuticals, Inc.
Filed: December 19, 2022
Period of Report: December 19, 2022
Accession Number: 0001209191-22-062073

View Document ↗ View on SEC.gov ↗